18F-氟化钠骨PET-CT在有症状腰骶移行椎中的应用
本研究纳入55例腰骶移行椎患者(34例有症状、21例无症状),采用18F-NaF PET/CT评估示踪剂摄取,使用三点分级法。有症状组多数为2级摄取,无症状组多数为0级摄取,摄取强度与症状存在强线性趋势(p<0.0001);以摄取判断疼痛原因的敏感度82%、特异度86%。作者认为18F-NaF PET/CT可能有助于评估背痛。
要点
- 腰骶移行椎患者中,18F-NaF局灶性摄取增高(2级)更多见于有症状者。
- 无症状者多数无摄取(0级,n=18),有症状者多数为2级(n=24)。
- 以18F-NaF摄取判断疼痛原因的敏感度82%、特异度86%。
核心结论
- 18F-NaF PET/CT可能有助于评估背痛,18F-NaF可能作为评估腰骶移行椎是否为疼痛潜在原因的辅助生物学标志物。
研究设计与样本
- 研究纳入55例腰骶移行椎患者(平均年龄51.42岁,中位年龄52岁),其中34例有症状、21例无症状。
- 所有患者接受整合PET/CT,注射18F-NaF剂量为0.06 mCi/kg。
- 采用三点分级系统评估18F-NaF摄取:0级为无摄取,1级为轻度摄取,2级为摄取明显增高。
关键影像表现/征象
- 无症状患者多数无摄取,0级18例、1级3例。
- 有症状患者表现为局灶性示踪剂摄取增高,2级24例、1级4例、0级6例。
- 18F-NaF摄取强度与症状存在强线性趋势(p<0.0001)。
诊断标准与关键数值
- 以18F-NaF在腰骶移行椎处摄取作为疼痛原因的敏感度为82%(95%CI:65-93%),特异度为86%(95%CI:64-97%)。
- 阳性预测值为90%(95%CI:74-98%),阴性预测值为75%(95%CI:53-90%)。
临床应用与阅片要点
- 阅片时可对腰骶移行椎处18F-NaF摄取按0-2级分级描述,局灶性明显增高(2级)更多见于有症状患者。
- 作者认为18F-NaF PET/CT可能有助于评估背痛,18F-NaF可能作为辅助生物学标志物评估腰骶移行椎是否为疼痛潜在原因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To analyse the relationship between 18F-labelled sodium fluoride (NaF) uptake and lumbar back pain in patients with lumbosacral transitional vertebra (LSTV) a congenital malformation of the lumbosacral spine.
MATERIALS AND METHODS: The study population comprised 55 patients (mean age, 51.42 years; median age 52 years) with LSTV. All patients underwent integrated positron-emission tomography (PET)/computed tomography (CT) by injecting 0.06 mCi/kg of 18F-NaF. A three-point grading system was used to evaluate 18F-NaF uptake (grade 0, no uptake; grade 1, mild uptake; and grade 2, marked increase uptake.
RESULTS: In total, 55 cases of LSTV (34 symptomatic and 21 asymptomatic) were included. Asymptomatic patients had no uptake in the majority of cases, i.e., grade 0 (n=18) and grade 1 (n=3), whereas symptomatic patients demonstrated focal increase tracer uptake of grade 2 (n=24), grade 1 (n=4), and grade 0 (n=6). There is a strong linear trend between the intensity of 18F-NaF uptake and presence of symptoms (p<0.0001). The sensitivity and specificity of 18F-NaF uptake at LSTV as a cause of pain were 82% (95% confidence interval [CI]: 65-93%) and 86% (95% CI: 64-97%). The positive and negative predictive values were 90% (95% CI: 74-98%) and 75% (95% CI: 53-90%).
CONCLUSIONS: 18F-NaF PET/CT can be useful in evaluating back pain and 18F-NaF may be used as an adjunctive biological maker for assessing LSTV as a potential cause of pain.
引用
- Usmani S, Ahmed N, Marafi F, et al. 18F-sodium fluoride bone PET-CT in symptomatic lumbosacral transitional vertebra. Clin Radiol. 2020. PMID: 32299619. doi:10.1016/j.crad.2020.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。